FLNA Filana Therapeutics, Inc. - Common Stock
$1.21
가격 · 5월 20, 2026
기준 재무 정보 5월 7, 2026
52주 범위
$1–$2
8% of range
애널리스트 평점
BUY
7 analysts
목표 주가
$8
+561% upside
P/E (TTM)
—
ROE
-112.1%
순이익률
—
FLNA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$1.21
시가총액
—
P/E (TTM)
—
EPS (TTM)
$-1.88
매출 (TTM)
—
배당 수익률
—
ROE
-112.1%
부채/자본
—
52주 범위
$1 – $2
FLNA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-1.88
2022-12-31
→
2025-12-31
잉여현금흐름
$-33M
2016-12-31
→
2025-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
FLNA
동종업계 중앙값
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
FLNA
동종업계 중앙값
ROA
-66.0%
—
ROE
-112.1%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
FLNA
동종업계 중앙값
Current Ratio (유동비율)
2.2
—
Quick Ratio (당좌 비율)
2.2
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
FLNA
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
FLNA
동종업계 중앙값
배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR
배당 수익률
—
지급 비율
—
5년 배당 CAGR
—
| 배당락일 | 금액 |
|---|---|
| 2012년 12월 13일 | $5.2500 |
| 2010년 12월 13일 | $14.0000 |
FLNA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
7 명의 애널리스트
- 적극 매수 2 28.6%
- 매수 4 57.1%
- 보유 1 14.3%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
1 명의 애널리스트 · 2026-05-18
저가
$8.00
고가
$8.00
중앙값 목표
$8.00
+561.5%
평균 목표
$8.00
+561.5%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.16%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2025년 9월 30일 | $-0.22 | $-0.28 | 0.06% |
| 2025년 3월 31일 | $-0.48 | — | — |
| 2024년 12월 31일 | $-0.57 | $-0.67 | 0.10% |
| 2024년 9월 30일 | $-0.58 | $-0.90 | 0.32% |
동료 비교 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| FLNA | — | — | — | — | -112.1% | — |
| PLRX | $75M | -0.5 | -83.7% | — | -74.4% | — |
| RFL | — | -1.6 | 44.0% | -3328.2% | -34.6% | — |
| CING | — | — | — | — | — | — |
| IMA | — | -0.7 | -77.1% | -5668.6% | 192.1% | — |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | — |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $27M | $70M | $89M | $68M | $25M | · | · | $3M | $8M | $9M | $9M | $7M | |
| SG&A Expense | $69M | $72M | $17M | $12M | $8M | $4M | $3M | $4M | $4M | $6M | $5M | $5M | |
| Operating Expenses | $95M | $141M | $106M | $80M | $33M | $6M | $5M | $7M | $12M | $15M | $14M | $12M | |
| Operating Income | $-95M | $-141M | $-106M | $-80M | $-33M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M | |
| Other Non-op | $-203.0K | $411.0K | $907.0K | $997.0K | $434.0K | · | · | · | · | · | · | · | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-14M | $-12M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-91M | $-24M | $-97M | $-76M | $-32M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M | |
| EPS (Basic) | $-1.88 | $-0.53 | $-2.32 | $-1.90 | $-0.82 | · | · | · | · | · | $-0.31 | $-0.27 | |
| EPS (Diluted) | $-1.88 | $-1.46 | $-2.32 | $-1.90 | · | · | · | · | · | · | $-0.31 | $-0.27 | |
| Shares (Basic) | 48,297,000 | 46,329,000 | 41,932,000 | 40,202,000 | 39,405,000 | · | · | · | · | · | 45,756,000 | 45,269,000 | |
| Shares (Diluted) | 48,297,000 | 46,604,000 | 41,932,000 | 40,202,000 | · | · | · | · | · | · | 45,756,000 | 45,269,000 | |
| EBITDA | $-95M | $-141M | $-106M | $-80M | $-33M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M |
대차대조표 24
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96M | $129M | $121M | $201M | $233M | $94M | $23M | $20M | $10M | $17M | $31M | $41M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $2M | · | · | |
| Prepaid Expense | $2M | $8M | $8M | $10M | $11M | $488.0K | $268.0K | · | · | · | · | · | |
| Other Current Assets | $64.0K | $38.0K | $287.0K | $160.0K | · | $488.0K | $268.0K | $233.0K | $184.0K | $356.0K | $392.0K | $239.0K | |
| Current Assets | $98M | $137M | $130M | $211M | $244M | $94M | $23M | $20M | $11M | $19M | $32M | $41M | |
| PP&E (Net) | $21M | $21M | $22M | $23M | $21M | $11.0K | $47.0K | $87.0K | $156.0K | $232.0K | $215.0K | $65.0K | |
| PP&E (Gross) | $25M | $24M | $24M | $24M | $21M | $97.0K | · | · | · | · | · | · | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $396.0K | $86.0K | $900.0K | $900.0K | $800.0K | $700.0K | $700.0K | $600.0K | |
| Intangibles | $193.0K | $37.0K | $176.0K | $622.0K | $1M | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | $399.0K | · | · | $12.0K | $12.0K | · | $12.0K | $12.0K | |
| Total Assets | $118M | $158M | $152M | $235M | $267M | $94M | $23M | $20M | $11M | $19M | $32M | $41M | |
| Accounts Payable | · | · | · | $4M | $7M | $911.0K | $453.0K | $294.0K | $424.0K | $303.0K | $1M | $173.0K | |
| Accrued Liabilities | · | · | · | $2M | $3M | $719.0K | $777.0K | $156.0K | $399.0K | $27.0K | $894.0K | $25.0K | |
| Current Liabilities | $44M | $12M | $14M | $7M | $13M | $2M | $1M | $511.0K | $1M | $665.0K | $3M | $850.0K | |
| Capital Leases | · | · | $0 | $35.0K | $139.0K | $235.0K | · | · | · | · | · | · | |
| Other Non-current Liabilities | $118.0K | $79.0K | $0 | $197.0K | $194.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $44M | $12M | $14M | $7M | $13M | $2M | $1M | $511.0K | $1M | $665.0K | $3M | $850.0K | |
| Common Stock | $48.0K | $48.0K | $42.0K | $42.0K | $40.0K | $35.0K | $22.0K | $17.0K | $7.0K | $7.0K | $46.0K | $46.0K | |
| Paid-in Capital | $570M | $551M | $518M | $511M | $461M | $267M | $191M | $184M | $167M | $164M | $160M | $157M | |
| Retained Earnings | $-496M | $-405M | $-381M | $-284M | $-207M | $-175M | $-169M | $-164M | $-157M | $-145M | $-131M | $-116M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $1.0K | |
| Stockholders' Equity | $74M | $146M | $137M | $228M | $254M | $92M | $22M | $20M | $10M | $19M | $29M | $40M | |
| Liabilities + Equity | $118M | $158M | $152M | $235M | $267M | $94M | $23M | $20M | $11M | $19M | $32M | $41M | |
| Shares Outstanding | 48,307,896 | 48,203,179 | 42,236,919 | 41,735,557 | 40,016,792 | 35,237,987 | 21,841,810 | 17,219,300 | 6,595,509 | 6,591,705 | 45,756,117 | 45,756,117 |
현금 흐름 12
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $22.0K | $58.0K | $69.0K | $68.0K | $58.0K | $45.0K | $15.0K | |
| Stock-based Comp | $20M | $16M | $5M | $2M | $2M | $988.0K | $1M | $2M | $3M | $4M | $3M | $4M | |
| Amort. of Intangibles | $33.0K | $180.0K | $446.0K | $497.0K | $224.0K | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | $-58.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $-117M | $-82M | $-78M | $-30M | $-5M | $-3M | $-5M | $-8M | $-12M | $-9M | $-10M | |
| CapEx | $581.0K | $103.0K | $414.0K | $3M | $22M | · | $18.0K | · | · | $75.0K | $195.0K | $80.0K | |
| Investing Cash Flow | $-581.0K | $-103.0K | $-414.0K | $-3M | $-22M | $360.0K | $-18.0K | · | $2M | $-2M | · | · | |
| Stock Issued | · | $0 | $0 | $47M | $190M | $70M | · | $14M | · | · | · | $379.0K | |
| Net Stock Activity | · | $0 | $0 | $47M | $190M | · | · | $14M | · | · | · | $379.0K | |
| Financing Cash Flow | $-239.0K | $124M | $3M | $48M | $192M | $75M | $6M | $14M | · | $-284.0K | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $9M | $-6M | $-15M | $-9M | $-8M | |
| Free Cash Flow | $-33M | $-117M | $-82M | $-80M | $-52M | · | $-3M | · | · | $-12M | $-9M | $-10M |
수익성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -66.0% | -15.8% | -50.3% | -30.4% | -17.9% | -10.8% | -21.2% | -42.3% | -79.1% | -58.0% | -38.9% | -27.2% | |
| ROE | -112.1% | -15.6% | -66.5% | -35.8% | -12.4% | -11.1% | -22.2% | -44.7% | -84.1% | -61.9% | -40.8% | -28.0% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 11.6 | 9.1 | 29.9 | 19.5 | 50.4 | 16.8 | 39.2 | 9.4 | 28.7 | 12.4 | 48.0 | |
| Quick Ratio | 2.2 | 10.9 | 8.5 | 28.5 | 18.6 | 50.1 | 16.6 | 38.8 | 9.3 | 28.1 | 12.3 | 47.8 |
가치 평가 (TTM) 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | |
| Net Income TTM | $-91M | $-24M | $-97M | $-76M | $-32M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M |
손익계산서 12
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $4M | $4M | $5M | $14M | $21M | $18M | $15M | $16M | $24M | $25M | $22M | $19M | · | · | · | |
| SG&A Expense | $7M | $10M | $8M | $40M | $11M | $9M | $13M | $46M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | |
| Operating Expenses | $11M | $14M | $12M | $45M | $25M | $29M | $31M | $61M | $20M | $28M | $29M | $27M | $21M | $20M | $18M | $10M | |
| Operating Income | $-11M | $-14M | $-12M | $-45M | $-25M | $-29M | $-31M | $-61M | $-20M | $-28M | $-29M | $-27M | $-21M | $-20M | $-18M | $-10M | |
| Other Non-op | $48.0K | $39.0K | $-114.0K | $-46.0K | $-82.0K | $90.0K | $62.0K | $99.0K | $160.0K | $223.0K | $203.0K | $190.0K | $210.0K | $275.0K | $263.0K | $176.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-10M | $-13M | $-11M | $-44M | $-23M | $-28M | $-28M | $6M | $25M | $-26M | $-26M | $-24M | $-20M | $-19M | $-18M | $-10M | |
| EPS (Basic) | $-0.21 | $-0.26 | $-0.22 | $-0.92 | $-0.48 | $-0.66 | $-0.58 | $0.13 | $0.58 | $-0.61 | $-0.63 | $-0.58 | $-0.51 | $-0.48 | · | · | |
| EPS (Diluted) | · | $-0.26 | $-0.22 | $-0.92 | $-0.48 | $-0.58 | $-0.58 | $0.13 | $-0.43 | $-0.61 | $-0.63 | $-0.58 | · | $-0.48 | $-0.44 | · | |
| Shares (Basic) | · | -96,581,000 | 48,308,000 | 48,308,000 | 48,262,000 | -90,850,000 | 47,976,000 | 46,202,000 | 43,001,000 | 42,002,000 | 41,793,000 | 41,739,000 | 40,050,000 | 40,015,000 | · | · | |
| Shares (Diluted) | · | -96,581,000 | 48,308,000 | 48,308,000 | 48,262,000 | -91,676,000 | 47,976,000 | 46,202,000 | 44,102,000 | 42,002,000 | 41,793,000 | 41,739,000 | · | 40,015,000 | 39,962,000 | · | |
| EBITDA | $-11M | · | $-12M | $-45M | $-25M | · | $-31M | $-61M | $-20M | $-28M | $-29M | $-27M | $-21M | $-20M | $-18M | $-10M |
대차대조표 22
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $87M | $96M | $106M | $112M | $117M | $129M | $149M | $207M | $124M | $142M | $168M | $187M | $175M | $197M | $210M | $242M | |
| Prepaid Expense | $1M | $2M | $3M | $2M | $3M | $8M | $14M | $15M | $10M | $8M | $6M | $8M | $9M | $7M | $13M | $10M | |
| Other Current Assets | $220.0K | $64.0K | $106.0K | $134.0K | $162.0K | $38.0K | $192.0K | $161.0K | $218.0K | $189.0K | · | · | · | · | · | · | |
| Current Assets | $88M | $98M | $109M | $115M | $120M | $137M | $203M | $222M | $134M | $150M | $175M | $195M | $183M | $204M | $222M | $252M | |
| PP&E (Net) | $20M | $21M | $21M | $21M | $21M | $21M | $21M | $21M | $22M | $22M | $22M | $23M | $23M | $22M | $21M | $21M | |
| PP&E (Gross) | $25M | $25M | $25M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $23M | $21M | $21M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $929.0K | $748.0K | $574.0K | $217.0K | |
| Intangibles | · | $193.0K | · | · | · | $37.0K | $69.0K | $82.0K | $115.0K | $268.0K | $387.0K | $503.0K | $740.0K | $859.0K | $940.0K | $1M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $199.0K | |
| Total Assets | $108M | $118M | $130M | $135M | $141M | $158M | $224M | $244M | $156M | $173M | $197M | $218M | $207M | $227M | $244M | $274M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | $10M | $8M | $4M | $5M | $3M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | $7M | $5M | $4M | $3M | $3M | $3M | |
| Current Liabilities | $40M | $44M | $48M | $47M | $13M | $12M | $57M | $55M | $77M | $17M | $18M | $14M | $8M | $9M | $7M | $6M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | $0 | · | · | $62.0K | $88.0K | $114.0K | $164.0K | |
| Other Non-current Liabilities | $111.0K | $118.0K | $119.0K | $79.0K | $79.0K | $79.0K | $80.0K | · | · | $0 | · | $197.0K | $197.0K | $201.0K | $194.0K | $194.0K | |
| Total Liabilities | $40M | $44M | $48M | $47M | $13M | $12M | $57M | · | · | $17M | $18M | $14M | $9M | $9M | $7M | $7M | |
| Common Stock | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $43.0K | $42.0K | $42.0K | $42.0K | $40.0K | $40.0K | $40.0K | $40.0K | |
| Paid-in Capital | $575M | $570M | $565M | $561M | $556M | $551M | $544M | $538M | $434M | $515M | $514M | $512M | $463M | $462M | $462M | $461M | |
| Retained Earnings | $-506M | $-496M | $-484M | $-473M | $-429M | $-405M | $-378M | $-350M | $-356M | $-360M | $-334M | $-308M | $-264M | $-244M | $-225M | $-193M | |
| Stockholders' Equity | $68M | $74M | $82M | $88M | $128M | $146M | $167M | $189M | $79M | $155M | $179M | $204M | $199M | $218M | $237M | $268M | |
| Liabilities + Equity | $108M | $118M | $130M | $135M | $141M | $158M | $224M | $244M | $156M | $173M | $197M | $218M | $207M | $227M | $244M | $274M | |
| Shares Outstanding | 48,307,896 | 48,307,896 | 48,307,896 | 48,307,896 | 48,307,896 | 48,203,179 | 47,976,166 | 47,976,166 | 43,248,416 | 42,129,798 | 41,919,527 | 41,749,435 | 40,059,514 | 40,097,917 | 40,031,280 | 40,016,792 |
현금 흐름 8
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $5M | $4M | $5M | $5M | $6M | $6M | $3M | $2M | $949.0K | $835.0K | $673.0K | $470.0K | $485.0K | $495.0K | $572.0K | |
| Amort. of Intangibles | · | · | · | · | · | $31.0K | $32.0K | $56.0K | $61.0K | $119.0K | $119.0K | $119.0K | $119.0K | $125.0K | $135.0K | $90.0K | |
| Operating Cash Flow | $-9M | $-10M | $-6M | $-5M | $-11M | $-61M | $-18M | $-18M | $-19M | $-27M | $-20M | $-13M | $-22M | $-11M | $-24M | $-15M | |
| CapEx | · | $501.0K | $80.0K | $0 | $0 | $57.0K | $17.0K | $29.0K | $0 | $22.0K | $-6.0K | $357.0K | $1M | $1M | $425.0K | $22M | |
| Investing Cash Flow | · | $-501.0K | $-80.0K | $0 | $0 | $-57.0K | $-17.0K | $-29.0K | $0 | $-22.0K | $6.0K | $-357.0K | $-1M | $-1M | $-425.0K | $-22M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $-51.0K | $-329.0K | $0 | $0 | $90.0K | $918.0K | $0 | $101M | $22M | $464.0K | $889.0K | $64.0K | $136.0K | $119.0K | $211.0K | $75.0K | |
| Free Cash Flow | · | · | · | · | $-11M | · | · | · | $-19M | · | · | $-14M | · | · | $-24M | · |
수익성 2
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.3% | · | -6.1% | -23.3% | -15.8% | · | -14.1% | 2.8% | 13.4% | -13.5% | -12.4% | -10.5% | -8.4% | -7.6% | -6.6% | -6.4% | |
| ROE | -10.5% | · | -8.7% | -31.9% | -22.7% | · | -17.4% | 3.3% | 17.7% | -14.5% | -13.3% | -11.0% | -8.7% | -7.8% | -6.8% | -6.6% |
유동성 및 지급능력 2
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | · | 2.3 | 2.4 | 9.1 | · | 3.6 | 4.1 | 1.7 | 8.6 | 9.8 | 14.0 | 22.1 | 23.4 | 32.7 | 39.8 | |
| Quick Ratio | 2.2 | · | 2.2 | 2.4 | 8.9 | · | 2.6 | 3.8 | 1.6 | 8.2 | 9.4 | 13.5 | 21.0 | 22.6 | 30.9 | 38.2 |
가치 평가 (TTM) 2
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | · | $41M | $41M | $41M | · | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | |
| Net Income TTM | $-89M | · | $-106M | $-89M | $-20M | · | $-22M | $-21M | $-51M | $-97M | $-90M | $-81M | $-67M | $-52M | $-36M | $-20M |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-91M | $-24M | $-97M | $-76M | $-32M |
| 희석 EPS | $-1.88 | $-1.46 | $-2.32 | $-1.90 | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 2.2 | 11.6 | 9.1 | 29.9 | 19.5 |
| 당좌 비율 | 2.2 | 10.9 | 8.5 | 28.5 | 18.6 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-33M | $-117M | $-82M | $-80M | $-52M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.